51 filings
8-K
GOSS
Gossamer Bio Inc
12 Mar 24
Gossamer Bio Announces Appointment of Steven D. Nathan, M.D., and Skye Drynan
4:01pm
8-K
GOSS
Gossamer Bio Inc
5 Mar 24
Gossamer Bio Announces Fourth Quarter and Full-Year 2023 Financial Results and Provides Business Update
7:31am
8-K
GOSS
Gossamer Bio Inc
4 Mar 24
Other Events
4:02pm
8-K
GOSS
Gossamer Bio Inc
29 Nov 23
Gossamer Bio Announces Appointment of John Quisel, J.D., Ph.D., to its Board of Directors
4:01pm
8-K
GOSS
Gossamer Bio Inc
27 Nov 23
Departure of Directors or Certain Officers
4:01pm
8-K
u3u3366u94w7q
9 Nov 23
Gossamer Bio Announces Third Quarter 2023 Financial Results and Provides Business Update
7:31am
8-K
i08hn k9ba6
20 Oct 23
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
4:01pm
8-K
js4g164irlg
7 Sep 23
Departure of Directors or Certain Officers
5:00pm
8-K
5mubp5y51w
8 Aug 23
Gossamer Bio Announces Second Quarter 2023 Financial Results and Provides Business Update
4:01pm
8-K
ndiqgva9
20 Jul 23
Gossamer Bio Announces $212 Million Private Placement Financing
4:01pm
8-K
xc3uyr94h6aq
20 Jul 23
Interim TORREY OLE Update and PROSERA Phase 3 Design July 2023
7:50am
8-K
hi246uqics3j 86vzbhy
9 Jun 23
Amendments to Articles of Incorporation or Bylaws
4:14pm
8-K
p8l8zlezw3u44 ot75v
9 May 23
Gossamer Bio Announces First Quarter 2023 Financial Results and Provides Business Update
4:03pm
8-K
h099uu3d5ix
3 Apr 23
Other Events
4:01pm
8-K
msis z4nptwkn2
17 Mar 23
Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update
7:41am
8-K
s3e0f
6 Dec 22
Other Events
7:36am
8-K
h02m5 j7m6
3 Nov 22
Gossamer Bio Announces Third Quarter 2022 Financial Results and Provides Business Update
4:00pm
8-K
8s32vm
9 Aug 22
Gossamer Bio Announces Second Quarter 2022 Financial Results and Provides Business Update
8:08am
8-K
h543w
13 Jul 22
Gossamer Bio Announces $120 million Private Placement Financing
8:45am
8-K
8pttap11uz
10 Jun 22
Submission of Matters to a Vote of Security Holders
4:05pm